These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17931789)

  • 21. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells.
    Goetzl EJ; Dolezalova H; Kong Y; Zeng L
    Cancer Res; 1999 Sep; 59(18):4732-7. PubMed ID: 10493533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitigation of radiation injury by selective stimulation of the LPA(2) receptor.
    Kiss GN; Lee SC; Fells JI; Liu J; Valentine WJ; Fujiwara Y; Thompson KE; Yates CR; Sümegi B; Tigyi G
    Biochim Biophys Acta; 2013 Jan; 1831(1):117-25. PubMed ID: 23127512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of early gene induction and cell proliferation by lysophosphatidic acid in human amnion-derived WISH cells: role of phospholipase D-mediated pathway.
    Kim JI; Jo EJ; Lee HY; Kang HK; Lee YN; Kwak JY; Bae YS
    Biochem Pharmacol; 2004 Jul; 68(2):333-40. PubMed ID: 15194005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases.
    Grey A; Banovic T; Naot D; Hill B; Callon K; Reid I; Cornish J
    Endocrinology; 2001 Mar; 142(3):1098-106. PubMed ID: 11181524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells.
    Yatomi Y; Ohmori T; Rile G; Kazama F; Okamoto H; Sano T; Satoh K; Kume S; Tigyi G; Igarashi Y; Ozaki Y
    Blood; 2000 Nov; 96(10):3431-8. PubMed ID: 11071638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor.
    Hasegawa Y; Erickson JR; Goddard GJ; Yu S; Liu S; Cheng KW; Eder A; Bandoh K; Aoki J; Jarosz R; Schrier AD; Lynch KR; Mills GB; Fang X
    J Biol Chem; 2003 Apr; 278(14):11962-9. PubMed ID: 12554733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
    Im DS
    Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.
    Meyer zu Heringdorf D; Jakobs KH
    Biochim Biophys Acta; 2007 Apr; 1768(4):923-40. PubMed ID: 17078925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system.
    Ishii I; Contos JJ; Fukushima N; Chun J
    Mol Pharmacol; 2000 Nov; 58(5):895-902. PubMed ID: 11040035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurobiology of receptor-mediated lysophospholipid signaling. From the first lysophospholipid receptor to roles in nervous system function and development.
    Chun J; Weiner JA; Fukushima N; Contos JJ; Zhang G; Kimura Y; Dubin A; Ishii I; Hecht JH; Akita C; Kaushal D
    Ann N Y Acad Sci; 2000 Apr; 905():110-7. PubMed ID: 10818447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes.
    Noh SJ; Kim MJ; Shim S; Han JK
    J Cell Physiol; 1998 Aug; 176(2):412-23. PubMed ID: 9648929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists.
    Kranenburg O; Moolenaar WH
    Oncogene; 2001 Mar; 20(13):1540-6. PubMed ID: 11313900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs).
    Chun J; Contos JJ; Munroe D
    Cell Biochem Biophys; 1999; 30(2):213-42. PubMed ID: 10356643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of EDG receptors and lysophospholipids as their endogenous ligands in the respiratory tract.
    Racké K; Hammermann R; Juergens UR
    Pulm Pharmacol Ther; 2000; 13(3):99-114. PubMed ID: 10873548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes.
    Sorensen SD; Nicole O; Peavy RD; Montoya LM; Lee CJ; Murphy TJ; Traynelis SF; Hepler JR
    Mol Pharmacol; 2003 Nov; 64(5):1199-209. PubMed ID: 14573770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature.
    Chun J; Goetzl EJ; Hla T; Igarashi Y; Lynch KR; Moolenaar W; Pyne S; Tigyi G
    Pharmacol Rev; 2002 Jun; 54(2):265-9. PubMed ID: 12037142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions.
    Kiss GN; Fells JI; Gupte R; Lee SC; Liu J; Nusser N; Lim KG; Ray RM; Lin FT; Parrill AL; Sümegi B; Miller DD; Tigyi G
    Mol Pharmacol; 2012 Dec; 82(6):1162-73. PubMed ID: 22968304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate.
    Dolezalova H; Shankar G; Huang MC; Bikle DD; Goetzl EJ
    J Cell Biochem; 2003 Mar; 88(4):732-43. PubMed ID: 12577307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor.
    Goetzl EJ; Kong Y; Kenney JS
    Proc Assoc Am Physicians; 1999; 111(3):259-69. PubMed ID: 10354366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.